| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.84B | 25.30B | 21.18B | 27.41B | 25.45B | 16.16B |
| Gross Profit | 3.69B | 4.01B | 1.26B | 1.79B | 2.41B | 2.65B |
| EBITDA | 1.12B | 1.10B | 976.95M | 988.95M | 1.53B | 984.63M |
| Net Income | 555.36M | 549.14M | 527.69M | 493.46M | 885.82M | 479.94M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 8.69B | 8.73B | 7.61B | 7.85B | 6.73B |
| Cash, Cash Equivalents and Short-Term Investments | 79.38M | 79.38M | 105.89M | 121.42M | 187.04M | 64.61M |
| Total Debt | 0.00 | 1.10B | 1.58B | 942.45M | 1.49B | 1.66B |
| Total Liabilities | -6.09B | 2.59B | 2.96B | 2.23B | 2.90B | 2.68B |
| Stockholders Equity | 6.09B | 5.77B | 5.43B | 5.07B | 4.66B | 3.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 897.60M | -364.35M | 816.41M | 473.34M | 337.49M |
| Operating Cash Flow | 0.00 | 1.18B | 168.96M | 1.23B | 650.15M | 401.27M |
| Investing Cash Flow | 0.00 | -276.90M | -531.60M | -407.03M | -174.58M | -58.65M |
| Financing Cash Flow | 0.00 | -929.98M | 344.82M | -883.66M | -353.15M | -356.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹8.81B | 10.67 | ― | 1.23% | 0.69% | -7.54% | |
56 Neutral | ₹9.33B | 192.20 | ― | 0.56% | 16.82% | ― | |
49 Neutral | ₹6.89B | -28.23 | ― | 0.50% | -3.11% | -331.77% | |
47 Neutral | ₹8.45B | 139.43 | ― | 1.07% | -22.10% | -85.56% | |
46 Neutral | ₹6.83B | 28.69 | ― | ― | 16.43% | ― | |
46 Neutral | ₹9.65B | 98.35 | ― | 0.17% | 12.25% | -74.52% |
Jayant Agro-Organics Limited has announced the closure of its trading window for directors, promoters, designated employees and specified connected persons, in line with its internal code of conduct and the SEBI (Prohibition of Insider Trading) Regulations, 2015. The restriction will be in force from 1 January 2026 until 48 hours after the board approves and discloses the financial results and other specified matters for the quarter ended 31 December 2025, underscoring the company’s compliance focus and its effort to prevent insider trading ahead of sensitive financial disclosures.